Antibodies to lipopolysaccharides: some diagnostic and protective aspects.
Fomsgaard
A
A
Department of Infectious Diseases, University Hospital of Copenhagen, Denmark.
D000907:Antibodies, Bacterial / Q000276:immunology* / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000276:immunology*; D000992:Antitoxins / Q000276:immunology; D001424:Bacterial Infections / Q000628:therapy; D001782:Blood Donors; D002240:Carbohydrate Sequence; D004731:Endotoxins / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007167:Immunotherapy; D008050:Lipid A / Q000276:immunology; D008070:Lipopolysaccharides / Q000276:immunology*; D008969:Molecular Sequence Data; D011550:Pseudomonas aeruginosa / Q000276:immunology; D012772:Shock, Septic / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000992:Antitoxins; D004731:Endotoxins; D008050:Lipid A; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha